Studies of intratumoral injection of α-gal glycolipids in the syngeneic model of KO mice bearing cutaneous B16 melanoma [52,53], suggested that interaction of anti-Gal with α-gal glycolipids will induce several processes that are also likely to occur in human melanoma lesions undergoing such treatment. This evidence concerns the gene GAL and melanoma.